Rani Therapeutics Holdings annual debt-to-assets ratio
2020
2021
2022
2023
2024
2025
Rani Therapeutics Holdings Debt-to-Assets Ratio Growth & History (RANI)
Rani Therapeutics Holdings's debt-to-assets ratio was 0.07 for fiscal 2025.
View full Rani Therapeutics Holdings company overviewRani Therapeutics Holdings annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.07 | −0.74 | −90.92% |
| 2024 | 2024-12-31 | 0.81 | 0.29 | +56.05% |
| 2023 | 2023-12-31 | 0.52 | 0.24 | +85.81% |
| 2022 | 2022-12-31 | 0.28 | 0.28 | — |
| 2021 | 2021-12-31 | 0.00 | −0.05 | — |
| 2020 | 2020-12-31 | 0.05 | — | — |
Rani Therapeutics Holdings quarterly debt-to-assets ratio
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.06 | −1.22 | −95.44% |
| Q1 2026 | 2026-03-31 | 0.08 | −0.99 | −92.86% |
| Q4 2025 | 2025-12-31 | 0.07 | −0.74 | −90.92% |
| Q3 2025 | 2025-09-30 | 1.73 | 0.96 | +123.47% |
| Q2 2025 | 2025-06-30 | 1.28 | 0.47 | +58.70% |
| Q1 2025 | 2025-03-31 | 1.06 | 0.40 | +60.79% |
| Q4 2024 | 2024-12-31 | 0.81 | 0.29 | +56.05% |
| Q3 2024 | 2024-09-30 | 0.77 | 0.34 | +80.20% |
| Q2 2024 | 2024-06-30 | 0.81 | 0.44 | +121.00% |
| Q1 2024 | 2024-03-31 | 0.66 | 0.34 | +108.36% |
| Q4 2023 | 2023-12-31 | 0.52 | 0.24 | +85.81% |
| Q3 2023 | 2023-09-30 | 0.43 | 0.29 | +202.21% |
| Q2 2023 | 2023-06-30 | 0.36 | 0.36 | +3709.73% |
| Q1 2023 | 2023-03-31 | 0.32 | 0.31 | +3059.68% |
| Q4 2022 | 2022-12-31 | 0.28 | 0.28 | — |
| Q3 2022 | 2022-09-30 | 0.14 | 0.14 | — |
| Q2 2022 | 2022-06-30 | 0.01 | −0.04 | −80.94% |
| Q1 2022 | 2022-03-31 | 0.01 | — | — |
| Q4 2021 | 2021-12-31 | 0.00 | −0.05 | — |
| Q3 2021 | 2021-09-30 | 0.00 | — | — |
| Q2 2021 | 2021-06-30 | 0.05 | — | — |
| Q4 2020 | 2020-12-31 | 0.05 | — | — |
Rani Therapeutics Holdings debt-to-assets ratio trends
Over the last five fiscal years, Rani Therapeutics Holdings's debt-to-assets ratio increased from 0.05 to 0.07, a change of 0.03. The latest reported quarter, Q2 2026, shows 0.06.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rani Therapeutics Holdings source filings ↗